Psychological disorder
... •A mood disorder characterized by extreme and persistent feelings of despondency, worthlessness, and hopelessness – Prolonged, very severe ...
... •A mood disorder characterized by extreme and persistent feelings of despondency, worthlessness, and hopelessness – Prolonged, very severe ...
Handle With Care
... legal remedy regarding evaluation and intervention. State Regulation – ability to adapt to external stimulation. ...
... legal remedy regarding evaluation and intervention. State Regulation – ability to adapt to external stimulation. ...
System Signs & Symptoms Score
... legal remedy regarding evaluation and intervention. State Regulation – ability to adapt to external stimulation. ...
... legal remedy regarding evaluation and intervention. State Regulation – ability to adapt to external stimulation. ...
PDF - Research Review NZ
... revealed these rates were 6%, 40% and 54%, respectively. In clinical practice, when we see an episode of depression, the first question should be `Is this bipolar or unipolar’? This diagnosis has significant implications for treatment. ...
... revealed these rates were 6%, 40% and 54%, respectively. In clinical practice, when we see an episode of depression, the first question should be `Is this bipolar or unipolar’? This diagnosis has significant implications for treatment. ...
5HT - wmshp
... FDA Recommendations re; Citalopram Not recommended at doses greater than 40mg due to prolongation of QTc interval Not recommended for use in patients with congenital long QT syndrome, bradycardia, hypokalemia, hypomagnesemia, recent acute MI or uncompensated heart failure Not recommended in p ...
... FDA Recommendations re; Citalopram Not recommended at doses greater than 40mg due to prolongation of QTc interval Not recommended for use in patients with congenital long QT syndrome, bradycardia, hypokalemia, hypomagnesemia, recent acute MI or uncompensated heart failure Not recommended in p ...
year
... called light therapy. For people who are not severely depressed and are unable—or unwilling—to use antidepressant medications, light therapy may be the best initial treatment. Light therapy consists of regular, daily exposure to a “light box,” which artificially simulates high-intensity sunlight. Pr ...
... called light therapy. For people who are not severely depressed and are unable—or unwilling—to use antidepressant medications, light therapy may be the best initial treatment. Light therapy consists of regular, daily exposure to a “light box,” which artificially simulates high-intensity sunlight. Pr ...
Substance Disorders
... For each substance be able to describe: effect of drug, withdrawal symptoms, dependency potential, risks, & societal impact Be familiar with the theories & treatments for substance disorders Classification of Substance-Related Disorders Substance Use Disorders: maladaptive use of psychoactive sub ...
... For each substance be able to describe: effect of drug, withdrawal symptoms, dependency potential, risks, & societal impact Be familiar with the theories & treatments for substance disorders Classification of Substance-Related Disorders Substance Use Disorders: maladaptive use of psychoactive sub ...
Bipolar disorder
... Types of bipolar disorder There are two main types of bipolar disorder: bipolar I (‘bipolar one’) and bipolar II (‘bipolar two’). These categories are based on the symptoms reported by the young person as well as the observations of others including family, friends or health care workers. An additio ...
... Types of bipolar disorder There are two main types of bipolar disorder: bipolar I (‘bipolar one’) and bipolar II (‘bipolar two’). These categories are based on the symptoms reported by the young person as well as the observations of others including family, friends or health care workers. An additio ...
1 introduction
... Ultra rapid metabolizer ......................................................................................... 56 ...
... Ultra rapid metabolizer ......................................................................................... 56 ...
An Overview of Mood Disorders Major Depression: An Overview
... Major Depressive Episode: Overview and Defining Features – Extremely depressed mood state lasting at least 2 weeks – Anhedonia – Loss of pleasure/interest in usual activities – Cognitive symptoms – Feelings of worthless, indecisiveness – Vegetative or somatic symptoms – Central to the disorder! ...
... Major Depressive Episode: Overview and Defining Features – Extremely depressed mood state lasting at least 2 weeks – Anhedonia – Loss of pleasure/interest in usual activities – Cognitive symptoms – Feelings of worthless, indecisiveness – Vegetative or somatic symptoms – Central to the disorder! ...
(PhVWP) July 2011 plenary meeting
... (SmPCs) and package leaflets (PLs) of those products authorised in the EU. The active substances included in the review were chlorpromazine, clotiapine, clozapine, fluphenazine, haloperidol, loxapine, molindone, perphenazine, pimozide, prochlorperazine, risperidone, thioridazine, thiothixene, triflu ...
... (SmPCs) and package leaflets (PLs) of those products authorised in the EU. The active substances included in the review were chlorpromazine, clotiapine, clozapine, fluphenazine, haloperidol, loxapine, molindone, perphenazine, pimozide, prochlorperazine, risperidone, thioridazine, thiothixene, triflu ...
Types of Bipolar Disorder
... People with bipolar disorder vary in how often they experience an episode of either mania or depression. Mood changes with bipolar disorder typically occur gradually. For some individuals there may be periods of wellness between the different mood episodes. Some people may also experience multiple e ...
... People with bipolar disorder vary in how often they experience an episode of either mania or depression. Mood changes with bipolar disorder typically occur gradually. For some individuals there may be periods of wellness between the different mood episodes. Some people may also experience multiple e ...
Child and Adolescent Bipolar Spectrum Services (CABS)
... (episodes of mania and depression), bipolar II (episodes of hypomania and depression), and bipolar, “not elsewhere classified,” (for people who have significant symptoms but are not bipolar I or II). ...
... (episodes of mania and depression), bipolar II (episodes of hypomania and depression), and bipolar, “not elsewhere classified,” (for people who have significant symptoms but are not bipolar I or II). ...
Bipolar disorder
... decline that is commonly seen in the prodromal phase of schizophrenia. During psychosis, the presence of first rank symptoms, more bizarre delusions, often mood incongruent, may point towards schizophrenia. Negative symptoms, such as apathy and decreased motivation and poverty of thought, are usuall ...
... decline that is commonly seen in the prodromal phase of schizophrenia. During psychosis, the presence of first rank symptoms, more bizarre delusions, often mood incongruent, may point towards schizophrenia. Negative symptoms, such as apathy and decreased motivation and poverty of thought, are usuall ...
Psychosis - Headspace
... Using or withdrawing from drugs, especially cannabis and amphetamines, can cause psychotic symptoms that last for short or long periods ...
... Using or withdrawing from drugs, especially cannabis and amphetamines, can cause psychotic symptoms that last for short or long periods ...
The case for long-acting antipsychotic agents in the post
... in the post-CATIE era Nasrallah HA. The case for long-acting antipsychotic agents in the postCATIE era. Objective: Long-acting antipsychotic agents were developed to promote treatment compliance in patients requiring maintenance treatment for schizophrenia. Method: An analysis of the impact of non-c ...
... in the post-CATIE era Nasrallah HA. The case for long-acting antipsychotic agents in the postCATIE era. Objective: Long-acting antipsychotic agents were developed to promote treatment compliance in patients requiring maintenance treatment for schizophrenia. Method: An analysis of the impact of non-c ...
Name: Block:______ Hanscom 2001 Cultural differences in PTSD
... and “making sense” of their symptoms. A survivor often states that he or she is “loosing my mind” or states that “my spirit has left me”. With this come feelings of powerlessness, helplessness, vulnerability and doom. Thus, this element of treatment involves assisting the survivor in understanding t ...
... and “making sense” of their symptoms. A survivor often states that he or she is “loosing my mind” or states that “my spirit has left me”. With this come feelings of powerlessness, helplessness, vulnerability and doom. Thus, this element of treatment involves assisting the survivor in understanding t ...
Issues in diagnosis Sz 2012 new
... Birmingham mental hospitals: 2/3 of psychotic patients were African-Caribbean, compared with only 1/3 who were white or Asian. This suggests....... ...
... Birmingham mental hospitals: 2/3 of psychotic patients were African-Caribbean, compared with only 1/3 who were white or Asian. This suggests....... ...
• Care of the Patient with a Psychiatric Disorder • The nurse should
... Agoraphobia: High anxiety brought on by possible situation such as people, places, or events Obsessive-compulsive disorder: Recurrent, intrusive, and senseless thoughts and behaviors that are performed in response to the obsessive thoughts Posttraumatic stress disorder (PTSD): Response to an intense ...
... Agoraphobia: High anxiety brought on by possible situation such as people, places, or events Obsessive-compulsive disorder: Recurrent, intrusive, and senseless thoughts and behaviors that are performed in response to the obsessive thoughts Posttraumatic stress disorder (PTSD): Response to an intense ...
2.2 What are Mood Disorders? - Counselling and Psychotherapy in
... that is judged to be a direct physiological consequence of a drug of abuse, a medication, another somatic treatment for depression, or toxin exposure. Mood Disorder Not Otherwise Specified: Mood symptoms that do not meet the criteria for any specific Mood Disorder and are hard to choose between Depr ...
... that is judged to be a direct physiological consequence of a drug of abuse, a medication, another somatic treatment for depression, or toxin exposure. Mood Disorder Not Otherwise Specified: Mood symptoms that do not meet the criteria for any specific Mood Disorder and are hard to choose between Depr ...
Antipsychotic
Antipsychotics (also known as neuroleptics or major tranquilizers) are a class of psychiatric medication primarily used to manage psychosis (including delusions, hallucinations, or disordered thought), in particular in schizophrenia and bipolar disorder, and are increasingly being used in the management of non-psychotic disorders (ATC code N05A). The word neuroleptic originates from the Greek word νεῦρον neuron (""nerve"") and λῆψις lepsis (""seizure"", ""fit"", ""occupation"").First-generation antipsychotics, known as typical antipsychotics, were discovered in the 1950s. Most second-generation drugs, known as atypical antipsychotics, have been developed more recently, although the first atypical antipsychotic, clozapine, was discovered in the 1950s and introduced clinically in the 1970s. Both generations of medication tend to block receptors in the brain's dopamine pathways, but atypicals tend to act on serotonin receptors as well.Antipsychotics are more effective than placebo in treating symptoms of psychosis, but some people do not respond fully or even partly to treatment. Their use is associated with significant side effects, most notably movement disorders and weight gain.